Considering that EGFR is a widespread tumor marker also expressed on normal epithelial cells, the UniCAR technology might be an appropriate solution for efficient EGFR-targeted therapy that simultaneously provides the necessary control mechanisms. Here, EGFR is linked to neoplasm.